On-Body Injector: An Administration Device for Pegfilgrastim.

Clinical journal of oncology nursing

PubMedID: 28107322

Mahler LJ, DiBlasi R, Perez A, Gaspard J, McCauley D. On-Body Injector: An Administration Device for Pegfilgrastim. Clin J Oncol Nurs. 2017;21(1):121-122.
Many chemotherapy regimens used today require the support of a ?granulocyte-colony-stimulating factor for the prevention of ?life-threatening neutropenia. In March 2015, a delivery method was introduced for Neulasta® (pegfilgrastim) through an on-body injector (Onpro®), which may eliminate the need for patients to return for injection after chemotherapy, increase workflow, and allow more patients to be seen. The purpose of this study was to monitor the implementation of the Onpro delivery system in an outpatient facility. .